IRBESARTAN/HYDROCHLOROTHIAZID MYLAN

300MG/12,5MG TBL NOB 28

SÚKL code 0179771
Name of the product IRBESARTAN/HYDROCHLOROTHIAZID MYLAN 300 MG/12,5 MG
_MA_MEDICATION_DETAIL_INFO_MED_NAME i IRBESARTAN/HYDROCHLOROTHIAZID MYLAN
Supplement 300MG/12,5MG TBL NOB 28
Strenght 300MG/12,5MG
Pharmaceutical form Tablet
Package 28
Route Oral use
Language of the pack Czech
Wrap type Blister
Legal status na lékařský předpis
Active substance HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDUM)
IRBESARTAN (IRBESARTANUM)
ATC group C09DA04
ATC group name IRBESARTAN A DIURETIKA
Doping Diuretika a ostatní maskovací látky (nelze pro léčbu sportovců použít vůbec). Bližší informace viz http://www.antidoping.cz/.

Marketing authorisation information

Registration Number 58/ 096/13-C
Type of MA A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state
MA status B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till)
Placed on the market till 28. 02. 2019
MA Holder Generics [UK] Limited, Potters Bar
MA Holder country VELKÁ BRITÁNIE
Actual MA holder Mylan Ireland Limited, Dublin
Actual MA holder country IRSKO

Back to list